Hepatitis C virus infection in dialysis patients

الملخص EN

Despite the introduction of strict hygienic precautions preventing infection spread of hepatitis C virus (HCV) in dialysis settings, this infection is still prevalent among dialysis patients due to procedures making the patients vulnerable to infection through blood contamination.

Treatment of HCV infection in dialysis patients is also less successful than that in the nonuremic population due to contraindication of using ribavirin, a main drug, in the infected patients.

In this review article we aim to investigate the feasibility of the current antiviral therapies in dialysis patients infected with HCV infection.